Effect of inhibition of iIntestinal cholesterol absorption on the prevention of cholesterol gallstone formation

Piero Portincasa, David Q.H. Wang

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Abstract: Background: Cholesterol cholelithiasis is a multifactorial hepatobiliary disease. Methods: Interactions between genetic and environmental factors play a critical role in biliary cholesterol homeostasis and its imbalance enhances cholelithogenesis. Results: In patients developing symptoms or complications of gallstone disease, laparoscopic cholecystectomy is recommended for treatment of gallstones. In a subgroup of patients with small, radiolucent pure cholesterol gallstones, the hydrophilic bile acid, ursodeoxycholic acid (UDCA) is still considered the only pharmacological therapy able to induce oral litholysis. Identifying novel and effective pharmacological therapies is being investigated. Conclusions: We propose that the specific intestinal Niemann-Pick C1-like 1 protein inhibitor ezetimibe is a potential agent for preventing gallstone formation by reducing bioavailability of intestine-derived cholesterol to the liver for biliary secretion and desaturating bile through the inhibition of intestinal absorption of cholesterol.

Original languageEnglish (US)
Pages (from-to)421-429
Number of pages9
JournalMedicinal Chemistry
Volume13
Issue number5
DOIs
StatePublished - Aug 1 2017
Externally publishedYes

Fingerprint

Gallstones
Cholesterol
Pharmacology
Ursodeoxycholic Acid
Cholelithiasis
Laparoscopic Cholecystectomy
Intestinal Absorption
Bile Acids and Salts
Bile
Biological Availability
Intestines
Homeostasis
Therapeutics
Liver
Proteins

Keywords

  • Brush border
  • Ezetimibe
  • Gallstones
  • Intestinal cholesterol absorption
  • Niemann-Pick C1-like 1 protein

ASJC Scopus subject areas

  • Drug Discovery

Cite this

Effect of inhibition of iIntestinal cholesterol absorption on the prevention of cholesterol gallstone formation. / Portincasa, Piero; Wang, David Q.H.

In: Medicinal Chemistry, Vol. 13, No. 5, 01.08.2017, p. 421-429.

Research output: Contribution to journalArticle

@article{aab7cd40e8804b18875f1c9175b28129,
title = "Effect of inhibition of iIntestinal cholesterol absorption on the prevention of cholesterol gallstone formation",
abstract = "Abstract: Background: Cholesterol cholelithiasis is a multifactorial hepatobiliary disease. Methods: Interactions between genetic and environmental factors play a critical role in biliary cholesterol homeostasis and its imbalance enhances cholelithogenesis. Results: In patients developing symptoms or complications of gallstone disease, laparoscopic cholecystectomy is recommended for treatment of gallstones. In a subgroup of patients with small, radiolucent pure cholesterol gallstones, the hydrophilic bile acid, ursodeoxycholic acid (UDCA) is still considered the only pharmacological therapy able to induce oral litholysis. Identifying novel and effective pharmacological therapies is being investigated. Conclusions: We propose that the specific intestinal Niemann-Pick C1-like 1 protein inhibitor ezetimibe is a potential agent for preventing gallstone formation by reducing bioavailability of intestine-derived cholesterol to the liver for biliary secretion and desaturating bile through the inhibition of intestinal absorption of cholesterol.",
keywords = "Brush border, Ezetimibe, Gallstones, Intestinal cholesterol absorption, Niemann-Pick C1-like 1 protein",
author = "Piero Portincasa and Wang, {David Q.H.}",
year = "2017",
month = "8",
day = "1",
doi = "10.2174/1573406413666170209122851",
language = "English (US)",
volume = "13",
pages = "421--429",
journal = "Medicinal Chemistry",
issn = "1573-4064",
publisher = "Bentham Science Publishers B.V.",
number = "5",

}

TY - JOUR

T1 - Effect of inhibition of iIntestinal cholesterol absorption on the prevention of cholesterol gallstone formation

AU - Portincasa, Piero

AU - Wang, David Q.H.

PY - 2017/8/1

Y1 - 2017/8/1

N2 - Abstract: Background: Cholesterol cholelithiasis is a multifactorial hepatobiliary disease. Methods: Interactions between genetic and environmental factors play a critical role in biliary cholesterol homeostasis and its imbalance enhances cholelithogenesis. Results: In patients developing symptoms or complications of gallstone disease, laparoscopic cholecystectomy is recommended for treatment of gallstones. In a subgroup of patients with small, radiolucent pure cholesterol gallstones, the hydrophilic bile acid, ursodeoxycholic acid (UDCA) is still considered the only pharmacological therapy able to induce oral litholysis. Identifying novel and effective pharmacological therapies is being investigated. Conclusions: We propose that the specific intestinal Niemann-Pick C1-like 1 protein inhibitor ezetimibe is a potential agent for preventing gallstone formation by reducing bioavailability of intestine-derived cholesterol to the liver for biliary secretion and desaturating bile through the inhibition of intestinal absorption of cholesterol.

AB - Abstract: Background: Cholesterol cholelithiasis is a multifactorial hepatobiliary disease. Methods: Interactions between genetic and environmental factors play a critical role in biliary cholesterol homeostasis and its imbalance enhances cholelithogenesis. Results: In patients developing symptoms or complications of gallstone disease, laparoscopic cholecystectomy is recommended for treatment of gallstones. In a subgroup of patients with small, radiolucent pure cholesterol gallstones, the hydrophilic bile acid, ursodeoxycholic acid (UDCA) is still considered the only pharmacological therapy able to induce oral litholysis. Identifying novel and effective pharmacological therapies is being investigated. Conclusions: We propose that the specific intestinal Niemann-Pick C1-like 1 protein inhibitor ezetimibe is a potential agent for preventing gallstone formation by reducing bioavailability of intestine-derived cholesterol to the liver for biliary secretion and desaturating bile through the inhibition of intestinal absorption of cholesterol.

KW - Brush border

KW - Ezetimibe

KW - Gallstones

KW - Intestinal cholesterol absorption

KW - Niemann-Pick C1-like 1 protein

UR - http://www.scopus.com/inward/record.url?scp=85026742566&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85026742566&partnerID=8YFLogxK

U2 - 10.2174/1573406413666170209122851

DO - 10.2174/1573406413666170209122851

M3 - Article

VL - 13

SP - 421

EP - 429

JO - Medicinal Chemistry

JF - Medicinal Chemistry

SN - 1573-4064

IS - 5

ER -